DBV Technologies S.A.

2.5000.00Vol 264.77K1Y Perf -56.37%
Jun 24th, 2022 16:00 DELAYED
BID2.44 ASK2.51
Open2.42 Previous Close2.50
Pre-Market- After-Market2.51
 - -  0.01 0.40%
Target Price
5.50 
Analyst Rating
Moderate Buy 1.67
Potential %
120.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.33
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
27.89 
Earnings Rating
Strong Buy
Market Cap469.22M 
Earnings Date
1st Aug 2022
Alpha-0.04 Standard Deviation0.27
Beta2.15 

Today's Price Range

2.352.52

52W Range

1.155.99

5 Year PE Ratio Range

-8.80-3.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
11.11%
1 Month
78.56%
3 Months
58.23%
6 Months
47.93%
1 Year
-56.37%
3 Years
-69.33%
5 Years
-93.23%
10 Years
-

TickerPriceChg.Chg.%
DBVT2.500.00000.00
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.47-0.1568.09
Q04 2021-0.32-0.1359.38
Q03 2021-0.29-0.2224.14
Q02 2021-0.64-0.2856.25
Q01 2021-0.39-0.2730.77
----
----
----
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.1726.09Positive
9/2022 QR-0.1719.05Positive
12/2022 FY-0.6921.59Positive
12/2023 FY-0.6521.69Positive
Next Report Date1st Aug 2022
Estimated EPS Next Report-0.17
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume264.77K
Shares Outstanding187.69K
Shares Float187.57M
Trades Count1.44K
Dollar Volume646.33K
Avg. Volume793.79K
Avg. Weekly Volume153.44K
Avg. Monthly Volume1.51M
Avg. Quarterly Volume717.56K

DBV Technologies S.A. (NASDAQ: DBVT) stock closed at 2.5 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 264.77K shares and market capitalization of 469.22M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 311 people. DBV Technologies S.A. CEO is Daniel Tasse.

The one-year performance of DBV Technologies S.A. stock is -56.37%, while year-to-date (YTD) performance is 56.25%. DBVT stock has a five-year performance of -93.23%. Its 52-week range is between 1.15 and 5.9899, which gives DBVT stock a 52-week price range ratio of 27.89%

DBV Technologies S.A. currently has a PE ratio of -4.20, a price-to-book (PB) ratio of 4.36, a price-to-sale (PS) ratio of 64.92, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -52.08%, a ROC of -60.70% and a ROE of -70.36%. The company’s profit margin is -%, its EBITDA margin is 1 487.80%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from DBV Technologies S.A., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. DBV Technologies S.A.’s next earnings report date is 01st Aug 2022.

The consensus rating of Wall Street analysts for DBV Technologies S.A. is Moderate Buy (1.67), with a target price of $5.5, which is +120.00% compared to the current price. The earnings rating for DBV Technologies S.A. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DBV Technologies S.A. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DBV Technologies S.A. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.39, ATR14 : 0.23, CCI20 : 69.80, Chaikin Money Flow : 0.47, MACD : 0.26, Money Flow Index : 77.42, ROC : 63.40, RSI : 63.81, STOCH (14,3) : 53.04, STOCH RSI : 1.00, UO : 76.33, Williams %R : -46.96), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DBV Technologies S.A. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Strong Buy
1.00

DBV Technologies S.A.

DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. DBV's method of delivering biologically active compounds to the immune system is through self-administered and noninvasive products. The company also explores potential applications of its platform in vaccines and other immune diseases.

CEO: Daniel Tasse

Telephone: +33 155427878

Address: 177-181 avenue Pierre Brossolette, Montrouge 92120, , FR

Number of employees: 311

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

40%60%

Bearish Bullish

52%48%

Bearish Bullish

49%51%

TipRanks News for DBVT

Tue, 03 May 2022 04:45 GMT DBV Technologies SA American (DBVT) Gets a Buy Rating from JMP Securities

- TipRanks. All rights reserved.

News

Stocktwits